Clinical trial
Aripiprazole Treatment of the Prodrome
NCT00169949 · Northwell Health, Other · Terminated
Key facts
| NCT number | NCT00169949 |
|---|---|
| Title | Aripiprazole Treatment of the Prodrome |
| Official title | Open-Label Study of Aripiprazole in Individuals at Risk for Chronic Mental Illness |
| Lead sponsor | Northwell Health, Other |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Prodromal Schizophrenia, Prodromal Psychosis |
| Intervention type | Drug |
| Interventions | aripiprazole |
| Enrollment | 30 |
| Start date | Jan 1, 2004 |
| Completion | May 1, 2006 |
| First posted | Sep 15, 2005 |
| Last update posted | Sep 25, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: